Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank 薬物名（臨床試験情報から抽出） KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 PEG-interleukin-2
(Polyethylene glycol-modified recombinant interleukin-2)		1件: PEG-interleukin-2---1件: 65 💬
2 Peginterferon beta-1a
(Polyethylene glycol-interferon beta-1a)		1件: Peginterferon BETA-1A1件: Peginterferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3 Polidocanol
(Polyethylene glycol 450 lauryl ether)		1件: Polidocanol2件: Laureth 4 ,
Polidocanol 💬 		--3件: 34, 278, 279 💬
4 Polyethylene glycol
(Polyethylene glycol)		3件: Macrogol; Macrogol 3350; Polyethylene glycol3件: Polyethylene glycol 3350 (Polyethylene glycol 3350, Polyethylene glycol),
Macrogol 4000 ,
Macrogol 6000 💬 		--15件: 6, 13, 26, 41, 46, 50, 60, 65, 76, 96, 97, 195, 246, 299, 337 💬